EHAB
Enhabit Inc
Price Chart
No historical data available
Latest Quote
$13.80
| Previous Close | $13.79 |
| Open | $13.79 |
| Day High | $13.81 |
| Day Low | $13.79 |
| Volume | 652,845 |
Stock Information
| Shares Outstanding | 51.23M |
| Total Debt | $480.10M |
| Cash Equivalents | $50.00M |
| Revenue | $1.06B |
| Net Income | $-3.20M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $706.91M |
| EPS (TTM) | $-0.07 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.17B |
| Sales | $1.06B |
| Income | $-3.20M |
| Book/sh | $10.53 |
| Cash/sh | $0.98 |
| Employees | 11K |
Financial Ratios
| Quick Ratio | 1.46 |
| Current Ratio | 1.56 |
| Debt/Eq | 82.22 |
| EPS Growth TTM | 7.90% |
Returns & Margins
| ROA | 3.08% |
| ROE | -0.19% |
| Gross Margin | 48.90% |
| Operating Margin | 4.38% |
| Profit Margin | -0.30% |
Ownership
| Insider Ownership | 3.66% |
| Institutional Ownership | 100.64% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 20.87 |
| P/S | 0.66 |
| P/B | 1.31 |
Analyst Data
| Recommendation | hold |
| Target Price | $13.80 |
Technical Indicators
| SMA20 | $13.75 |
| SMA50 | $13.76 |
| SMA200 | $10.26 |
| RSI | 75.00 |
| ATR | 0.0250 |
| Shares Float | 44.62M |
| Short Float | 2.44% |
| Short Ratio | 1.18 |
| Volatility | 0.96 |
| Rel Volume | 1.32 |
Performance History
| Week | +0.22% |
| Month | +0.66% |
| Quarter | +22.99% |
| 6 Months | +72.72% |
| YTD | +51.82% |
| Year | +31.81% |
| 3 Years | +2.15% |
| 10 Years | -44.80% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
About Enhabit Inc
Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery or injury, and respiratory diseases; and counseling for patients and their families regarding financial, personal, and social concerns that arise from a patient's health-related problems. Its Hospice segment offers nursing care; pain and symptom management; palliative and dietary counseling; social worker visits; spiritual counseling; and family member bereavement counseling to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is headquartered in Dallas, Texas.
đ° Latest News
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-14T21:50:02ZFast-paced Momentum Stock Enhabit (EHAB) Is Still Trading at a Bargain
Zacks âĸ 2026-05-14T12:55:01ZEnhabit (EHAB) Upgraded to Buy: Here's Why
Zacks âĸ 2026-05-13T16:00:06ZDocGo Inc. (DCGO) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-11T21:25:02ZInnovAge Holding Corp. (INNV) Reports Q3 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-05T22:05:10ZHow The Enhabit (EHAB) Narrative Is Resetting Around Kinderhookâs US$13.80 Cash Offer
Simply Wall St. âĸ 2026-04-26T16:04:42ZHow The Enhabit (EHAB) Story Is Shifting Toward Kinderhookâs US$13.80 Cash Deal
Simply Wall St. âĸ 2026-04-11T23:08:47ZHow The Enhabit (EHAB) Story Is Shifting After The Kinderhook US$13.80 Cash Offer
Simply Wall St. âĸ 2026-03-27T15:06:27ZEnhabit (EHAB) Q3 2025 Earnings Call Transcript
Motley Fool âĸ 2026-03-18T16:27:50ZEnhabit (EHAB) Q1 2025 Earnings Call Transcript
Motley Fool âĸ 2026-03-18T16:26:00ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $540,200,000 | $530,800,000 | $535,600,000 | $525,600,000 |
| Cost Of Revenue | $540,200,000 | $530,800,000 | $535,600,000 | $525,600,000 |
| Total Revenue | $1,060,000,000 | $1,034,800,000 | $1,046,300,000 | $1,071,100,000 |
| Operating Revenue | $1,060,000,000 | $1,034,800,000 | $1,046,300,000 | $1,071,100,000 |
| Expenses | ||||
| Interest Expense | $34,000,000 | $42,900,000 | $43,000,000 | $15,000,000 |
| Total Expenses | $996,200,000 | $988,200,000 | $1,008,100,000 | $973,500,000 |
| Other Income Expense | $-28,600,000 | $-161,700,000 | $-85,600,000 | $-108,100,000 |
| Other Non Operating Income Expenses | $19,100,000 | - | $200,000 | $900,000 |
| Net Non Operating Interest Income Expense | $-33,800,000 | $-42,900,000 | $-43,000,000 | $-15,000,000 |
| Interest Expense Non Operating | $34,000,000 | $42,900,000 | $43,000,000 | $15,000,000 |
| Operating Expense | $456,000,000 | $457,400,000 | $472,500,000 | $447,900,000 |
| General And Administrative Expense | $433,500,000 | $425,900,000 | $441,600,000 | $414,900,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-4,600,000 | $-156,200,000 | $-80,500,000 | $-40,400,000 |
| Net Interest Income | $-33,800,000 | $-42,900,000 | $-43,000,000 | $-15,000,000 |
| Interest Income | $200,000 | $0 | $0 | - |
| Normalized Income | $33,083,000 | $1,406,329 | $-5,519,912 | $45,710,000 |
| Net Income From Continuing And Discontinued Operation | $-4,600,000 | $-156,200,000 | $-80,500,000 | $-40,400,000 |
| Total Operating Income As Reported | $16,100,000 | $-115,100,000 | $-47,600,000 | $-11,400,000 |
| Net Income Common Stockholders | $-4,600,000 | $-156,200,000 | $-80,500,000 | $-40,400,000 |
| Net Income | $-4,600,000 | $-156,200,000 | $-80,500,000 | $-40,400,000 |
| Net Income Including Noncontrolling Interests | $-2,600,000 | $-154,000,000 | $-79,000,000 | $-38,300,000 |
| Net Income Continuous Operations | $-2,600,000 | $-154,000,000 | $-79,000,000 | $-38,300,000 |
| Pretax Income | $1,400,000 | $-158,000,000 | $-90,400,000 | $-25,500,000 |
| Special Income Charges | $-47,700,000 | $-161,700,000 | $-85,800,000 | $-109,000,000 |
| Interest Income Non Operating | $200,000 | $0 | $0 | - |
| Operating Income | $63,800,000 | $46,600,000 | $38,200,000 | $97,600,000 |
| Depreciation Amortization Depletion Income Statement | $22,500,000 | $31,500,000 | $30,900,000 | $33,000,000 |
| Depreciation And Amortization In Income Statement | $22,500,000 | $31,500,000 | $30,900,000 | $33,000,000 |
| Gross Profit | $519,800,000 | $504,000,000 | $510,700,000 | $545,500,000 |
| Earnings From Equity Interest | - | - | $0 | $0 |
| Per Share | ||||
| Diluted EPS | - | $-3.11 | $-1.61 | $1.26 |
| Basic EPS | - | $-3.11 | $-1.61 | $1.26 |
| Other | ||||
| Tax Effect Of Unusual Items | $-10,017,000 | $-4,093,671 | $-10,819,912 | $-22,890,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $105,600,000 | $78,100,000 | $69,300,000 | $131,500,000 |
| Total Unusual Items | $-47,700,000 | $-161,700,000 | $-85,800,000 | $-109,000,000 |
| Total Unusual Items Excluding Goodwill | $-47,700,000 | $-161,700,000 | $-85,800,000 | $-109,000,000 |
| Reconciled Depreciation | $22,500,000 | $31,500,000 | $30,900,000 | $33,000,000 |
| EBITDA (Bullshit earnings) | $57,900,000 | $-83,600,000 | $-16,500,000 | $22,500,000 |
| EBIT | $35,400,000 | $-115,100,000 | $-47,400,000 | $-10,500,000 |
| Diluted NI Availto Com Stockholders | $-4,600,000 | $-156,200,000 | $-80,500,000 | $-40,400,000 |
| Minority Interests | $-2,000,000 | $-2,200,000 | $-1,500,000 | $-2,100,000 |
| Tax Provision | $4,000,000 | $-4,000,000 | $-11,400,000 | $12,800,000 |
| Impairment Of Capital Assets | $47,700,000 | $161,700,000 | $85,800,000 | $109,000,000 |
| Selling General And Administration | $433,500,000 | $425,900,000 | $441,600,000 | $414,900,000 |
| Other Gand A | $433,500,000 | $425,900,000 | $441,600,000 | $414,900,000 |
| Diluted Average Shares | - | $50,200,000 | $49,900,000 | $49,700,000 |
| Basic Average Shares | - | $50,200,000 | $49,900,000 | $49,600,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-359,800,000 | $-434,600,000 | $-472,000,000 | $-505,700,000 |
| Total Assets | $1,167,100,000 | $1,226,000,000 | $1,433,600,000 | $1,526,800,000 |
| Total Non Current Assets | $961,500,000 | $1,033,300,000 | $1,223,500,000 | $1,315,000,000 |
| Other Non Current Assets | $2,400,000 | $4,700,000 | $5,300,000 | $5,200,000 |
| Goodwill And Other Intangible Assets | $893,800,000 | $958,100,000 | $1,141,700,000 | $1,247,400,000 |
| Other Intangible Assets | $38,500,000 | $58,100,000 | $80,000,000 | $102,600,000 |
| Current Assets | $205,600,000 | $192,700,000 | $210,100,000 | $211,800,000 |
| Other Current Assets | $16,100,000 | $13,200,000 | $15,600,000 | $23,600,000 |
| Restricted Cash | $1,900,000 | $1,900,000 | $2,400,000 | $4,300,000 |
| Receivables | $144,000,000 | $149,200,000 | $164,700,000 | $161,000,000 |
| Accounts Receivable | $144,000,000 | $149,200,000 | $164,700,000 | $149,600,000 |
| Allowance For Doubtful Accounts Receivable | $-1,200,000 | $-900,000 | $-1,100,000 | $-1,100,000 |
| Gross Accounts Receivable | $145,200,000 | $150,100,000 | $165,800,000 | $150,700,000 |
| Cash Cash Equivalents And Short Term Investments | $43,600,000 | $28,400,000 | $27,400,000 | $22,900,000 |
| Cash And Cash Equivalents | $43,600,000 | $28,400,000 | $27,400,000 | $22,900,000 |
| Taxes Receivable | - | - | $3,000,000 | $11,400,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $404,700,000 | $487,000,000 | $525,200,000 | $560,200,000 |
| Total Debt | $500,000,000 | $569,500,000 | $610,100,000 | $625,200,000 |
| Long Term Debt And Capital Lease Obligation | $465,100,000 | $534,400,000 | $575,800,000 | $588,100,000 |
| Long Term Debt | $426,000,000 | $492,600,000 | $530,100,000 | $560,000,000 |
| Current Debt And Capital Lease Obligation | $34,900,000 | $35,100,000 | $34,300,000 | $37,100,000 |
| Current Debt | $22,300,000 | $22,800,000 | $22,500,000 | $23,100,000 |
| Other Current Borrowings | $22,300,000 | $22,800,000 | $22,500,000 | $23,100,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $603,000,000 | $672,100,000 | $731,900,000 | $751,500,000 |
| Total Non Current Liabilities Net Minority Interest | $476,700,000 | $545,900,000 | $594,200,000 | $618,600,000 |
| Other Non Current Liabilities | $100,000 | - | $1,300,000 | $1,900,000 |
| Non Current Deferred Liabilities | $11,500,000 | $11,500,000 | $17,100,000 | $28,600,000 |
| Non Current Deferred Taxes Liabilities | $11,500,000 | $11,500,000 | $17,100,000 | $28,600,000 |
| Current Liabilities | $126,300,000 | $126,200,000 | $137,700,000 | $132,900,000 |
| Other Current Liabilities | $41,800,000 | $47,300,000 | $40,700,000 | $40,700,000 |
| Payables And Accrued Expenses | $49,600,000 | $43,800,000 | $62,700,000 | $55,100,000 |
| Payables | $9,200,000 | $6,700,000 | $15,800,000 | $12,100,000 |
| Accounts Payable | $9,200,000 | $6,700,000 | $7,600,000 | $3,800,000 |
| Other Payable | - | $5,400,000 | $8,200,000 | $8,300,000 |
| Total Tax Payable | - | - | - | $0 |
| Income Tax Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $534,000,000 | $523,500,000 | $669,700,000 | $741,700,000 |
| Total Equity Gross Minority Interest | $564,100,000 | $553,900,000 | $701,700,000 | $775,300,000 |
| Stockholders Equity | $534,000,000 | $523,500,000 | $669,700,000 | $741,700,000 |
| Gains Losses Not Affecting Retained Earnings | $0 | $-200,000 | $-500,000 | $-700,000 |
| Retained Earnings | $93,700,000 | $98,300,000 | $254,500,000 | $335,000,000 |
| Other Equity Adjustments | - | $-200,000 | $-500,000 | $-700,000 |
| Other | ||||
| Treasury Shares Number | $471,790 | $219,851 | $114,331 | - |
| Ordinary Shares Number | $50,723,245 | $50,369,917 | $50,053,375 | $50,099,716 |
| Share Issued | $51,195,035 | $50,589,768 | $50,167,706 | $50,099,716 |
| Tangible Book Value | $-359,800,000 | $-434,600,000 | $-472,000,000 | $-505,700,000 |
| Invested Capital | $982,300,000 | $1,038,900,000 | $1,222,300,000 | $1,324,800,000 |
| Working Capital | $79,300,000 | $66,500,000 | $72,400,000 | $78,900,000 |
| Capital Lease Obligations | $51,700,000 | $54,100,000 | $57,500,000 | $42,100,000 |
| Total Capitalization | $960,000,000 | $1,016,100,000 | $1,199,800,000 | $1,301,700,000 |
| Minority Interest | $30,100,000 | $30,400,000 | $32,000,000 | $33,600,000 |
| Treasury Stock | $3,800,000 | $1,700,000 | $600,000 | $0 |
| Additional Paid In Capital | $443,600,000 | $426,600,000 | $415,800,000 | $406,900,000 |
| Capital Stock | $500,000 | $500,000 | $500,000 | $500,000 |
| Common Stock | $500,000 | $500,000 | $500,000 | $500,000 |
| Preferred Stock | $0 | $0 | - | - |
| Long Term Capital Lease Obligation | $39,100,000 | $41,800,000 | $45,700,000 | $28,100,000 |
| Current Capital Lease Obligation | $12,600,000 | $12,300,000 | $11,800,000 | $14,000,000 |
| Current Accrued Expenses | $40,400,000 | $37,100,000 | $46,900,000 | $43,000,000 |
| Goodwill | $855,300,000 | $900,000,000 | $1,061,700,000 | $1,144,800,000 |
| Net PPE | $65,300,000 | $70,500,000 | $76,500,000 | $62,400,000 |
| Accumulated Depreciation | $-65,700,000 | $-55,000,000 | $-55,400,000 | $-52,400,000 |
| Gross PPE | $131,000,000 | $125,500,000 | $131,900,000 | $114,800,000 |
| Leases | $4,000,000 | $3,200,000 | $3,100,000 | $3,000,000 |
| Other Properties | $49,800,000 | $52,800,000 | $57,500,000 | $42,000,000 |
| Machinery Furniture Equipment | $77,200,000 | $69,500,000 | $71,300,000 | $69,800,000 |
| Properties | $0 | $0 | $0 | $0 |
| Dueto Related Parties Current | - | - | - | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $65,800,000 | $47,400,000 | $44,900,000 | $73,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $70,700,000 | $51,200,000 | $48,400,000 | $80,100,000 |
| Cash Flow From Continuing Operating Activities | $70,700,000 | $51,200,000 | $48,400,000 | $80,100,000 |
| Operating Gains Losses | $-19,200,000 | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-4,900,000 | $-3,800,000 | $-3,500,000 | $-7,100,000 |
| Investing Cash Flow | $16,700,000 | $-2,400,000 | $-5,300,000 | $-42,300,000 |
| Cash Flow From Continuing Investing Activities | $16,700,000 | $-2,400,000 | $-5,300,000 | $-42,300,000 |
| Net Other Investing Changes | $600,000 | $1,400,000 | $1,000,000 | $1,100,000 |
| Capital Expenditure Reported | - | - | - | - |
| Financing Activities | ||||
| Financing Cash Flow | $-72,200,000 | $-48,300,000 | $-40,500,000 | $-18,600,000 |
| Cash Flow From Continuing Financing Activities | $-72,200,000 | $-48,300,000 | $-40,500,000 | $-18,600,000 |
| Net Other Financing Charges | $-4,500,000 | $-4,700,000 | $-7,100,000 | $61,300,000 |
| Cash Dividends Paid | - | $0 | $0 | $-654,900,000 |
| Common Stock Dividend Paid | - | $0 | $0 | $-654,900,000 |
| Dividend Received Cfo | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-67,700,000 | $-43,600,000 | $-33,400,000 | $-15,000,000 |
| Interest Paid Supplemental Data | $32,400,000 | $42,700,000 | $40,600,000 | $13,100,000 |
| Income Tax Paid Supplemental Data | $1,400,000 | - | - | $11,900,000 |
| End Cash Position | $45,500,000 | $30,300,000 | $29,800,000 | $27,200,000 |
| Beginning Cash Position | $30,300,000 | $29,800,000 | $27,200,000 | $8,000,000 |
| Changes In Cash | $15,200,000 | $500,000 | $2,600,000 | $19,200,000 |
| Net Issuance Payments Of Debt | $-67,700,000 | $-43,600,000 | $-33,400,000 | $575,000,000 |
| Net Long Term Debt Issuance | $-67,700,000 | $-43,600,000 | $-33,400,000 | $575,000,000 |
| Long Term Debt Payments | $-67,700,000 | $-43,600,000 | $-33,400,000 | $-15,000,000 |
| Net Investment Purchase And Sale | $21,000,000 | $0 | $0 | - |
| Sale Of Investment | $21,000,000 | $0 | $0 | - |
| Net Business Purchase And Sale | $0 | $0 | $-2,800,000 | $-36,300,000 |
| Purchase Of Business | $0 | $0 | $-2,800,000 | $-36,300,000 |
| Net PPE Purchase And Sale | $-4,900,000 | $-3,800,000 | $-3,500,000 | $-7,100,000 |
| Purchase Of PPE | $-4,900,000 | $-3,800,000 | $-3,500,000 | $-7,100,000 |
| Change In Working Capital | $3,800,000 | $5,100,000 | $11,700,000 | $-29,200,000 |
| Change In Other Current Liabilities | $-5,400,000 | $-10,200,000 | $400,000 | $7,500,000 |
| Change In Payables And Accrued Expense | $6,300,000 | $-3,300,000 | $6,800,000 | $-30,800,000 |
| Change In Accrued Expense | $3,700,000 | $-2,300,000 | $3,000,000 | $-31,000,000 |
| Change In Payable | $2,600,000 | $-1,000,000 | $3,800,000 | $200,000 |
| Change In Account Payable | $2,600,000 | $-1,000,000 | $3,800,000 | $200,000 |
| Change In Prepaid Assets | $-2,300,000 | $3,100,000 | $19,100,000 | $-27,500,000 |
| Change In Receivables | $5,200,000 | $15,500,000 | $-14,600,000 | $21,600,000 |
| Changes In Account Receivables | $5,200,000 | $15,500,000 | $-14,600,000 | $21,600,000 |
| Other Non Cash Items | $1,900,000 | $900,000 | $1,700,000 | $700,000 |
| Stock Based Compensation | $16,600,000 | $11,700,000 | $8,900,000 | $9,200,000 |
| Asset Impairment Charge | $47,700,000 | $161,700,000 | $85,800,000 | $109,000,000 |
| Deferred Tax | $0 | $-5,700,000 | $-11,600,000 | $-4,300,000 |
| Deferred Income Tax | $0 | $-5,700,000 | $-11,600,000 | $-4,300,000 |
| Depreciation Amortization Depletion | $22,500,000 | $31,500,000 | $30,900,000 | $33,000,000 |
| Depreciation And Amortization | $22,500,000 | $31,500,000 | $30,900,000 | $33,000,000 |
| Gain Loss On Investment Securities | $-19,200,000 | - | - | - |
| Net Income From Continuing Operations | $-2,600,000 | $-154,000,000 | $-79,000,000 | $-38,300,000 |
| Issuance Of Debt | - | $0 | $0 | $590,000,000 |
| Long Term Debt Issuance | - | $0 | $0 | $590,000,000 |
| Earnings Losses From Equity Investments | - | - | $0 | $0 |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |